Westwood Holdings Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-12,712
| Closed | -$1.15M | – | 570 |
|
|
2022
Q4 | $1.15M | Sell |
12,712
-4,568
| -26% | -$385K | 0.01% | 342 |
|
|
2022
Q3 | $1.31M | Sell |
17,280
-14,302
| -45% | -$1.19M | 0.02% | 298 |
|
|
2022
Q2 | $2.67M | Sell |
31,582
-200
| -0.6% | -$17.5K | 0.03% | 267 |
|
|
2022
Q1 | $2.79M | Sell |
31,782
-2,822
| -8% | -$244K | 0.03% | 280 |
|
|
2021
Q4 | $3.03M | Buy |
34,604
+12,642
| +58% | +$1.05M | 0.03% | 269 |
|
|
2021
Q3 | $1.8M | Sell |
21,962
-1,482
| -6% | -$133K | 0.02% | 299 |
|
|
2021
Q2 | $2.14M | Sell |
23,444
-14,036
| -37% | -$1.25M | 0.02% | 275 |
|
|
2021
Q1 | $3.2M | Sell |
37,480
-4,408
| -11% | -$396K | 0.03% | 278 |
|
|
2020
Q4 | $3.96M | Buy |
41,888
+19,432
| +87% | +$1.7M | 0.05% | 260 |
|
|
2020
Q3 | $1.95M | Sell |
22,456
-971
| -4% | -$84.1K | 0.02% | 278 |
|
|
2020
Q2 | $2.05M | Buy |
23,427
+2,200
| +10% | +$190K | 0.03% | 283 |
|
|
2020
Q1 | $1.75M | Buy |
21,227
+1,240
| +6% | +$111K | 0.03% | 278 |
|
|
2019
Q4 | $1.89M | Buy |
19,987
+2,364
| +13% | +$212K | 0.02% | 312 |
|
|
2019
Q3 | $1.53M | Sell |
17,623
-1,265
| -7% | -$114K | 0.02% | 315 |
|
|
2019
Q2 | $1.72M | Sell |
18,888
-2,699
| -13% | -$228K | 0.02% | 321 |
|
|
2019
Q1 | $1.86M | Sell |
21,587
-561
| -3% | -$45K | 0.02% | 277 |
|
|
2018
Q4 | $1.7M | Sell |
22,148
-3,441
| -13% | -$268K | 0.02% | 263 |
|
|
2018
Q3 | $1.98M | Sell |
25,589
-7,151
| -22% | -$529K | 0.02% | 271 |
|
|
2018
Q2 | $2.22M | Sell |
32,740
-4,233
| -11% | -$292K | 0.02% | 280 |
|
|
2018
Q1 | $2.68M | Buy |
36,973
+4,852
| +15% | +$369K | 0.02% | 273 |
|
|
2017
Q4 | $2.42M | Sell |
32,121
-268
| -0.8% | -$20.2K | 0.02% | 280 |
|
|
2017
Q3 | $2.49M | Buy |
32,389
+265
| +0.8% | +$20K | 0.02% | 268 |
|
|
2017
Q2 | $2.4M | Buy |
32,124
+26,092
| +433% | +$1.85M | 0.02% | 271 |
|
|
2017
Q1 | $401K | Buy |
6,032
+318
| +6% | +$21.2K | ﹤0.01% | 351 |
|
|
2016
Q4 | $373K | Buy |
5,714
+335
| +6% | +$21.7K | ﹤0.01% | 399 |
|
|
2016
Q3 | $381K | Buy |
+5,379
| New | +$392K | ﹤0.01% | 402 |
|
|
2015
Q4 | – | Sell |
-5,747
| Closed | -$471K | – | 395 |
|
|
2015
Q3 | $471K | Sell |
5,747
-649,887
| -99% | -$57.8M | ﹤0.01% | 343 |
|
|
2015
Q2 | $57.8M | Buy |
655,634
+13,615
| +2% | +$1.25M | 0.43% | 96 |
|
|
2015
Q1 | $56.7M | Buy |
642,019
+11,048
| +2% | +$980K | 0.43% | 97 |
|
|
2014
Q4 | $52.4M | Buy |
630,971
+59,595
| +10% | +$4.94M | 0.4% | 96 |
|
|
2014
Q3 | $48.2M | Sell |
571,376
-512,057
| -47% | -$41.4M | 0.38% | 99 |
|
|
2014
Q2 | $87.9M | Buy |
1,083,433
+89,392
| +9% | +$7.03M | 0.65% | 58 |
|
|
2014
Q1 | $75.7M | Sell |
994,041
-968,953
| -49% | -$70.6M | 0.58% | 71 |
|
|
2013
Q4 | $141M | Buy |
1,962,994
+127,308
| +7% | +$8.85M | 1.09% | 26 |
|
|
2013
Q3 | $126M | Buy |
1,835,686
+22,270
| +1% | +$1.47M | 1.07% | 22 |
|
|
2013
Q2 | $115M | Buy |
+1,813,416
| New | +$118M | 1% | 23 |
|
Other funds holding NVS
Westwood Holdings Group's NVS Position: Q1 2023 in Review
Westwood Holdings Group sold out of Novartis (NVS) in Q1 2023, closing a stake of 12,712 shares — an estimated $1.15M sold.
Westwood Holdings Group first reported a position in NVS in Q2 2013 and held it in 36 quarters. The position peaked at $141M in Q4 2013. 1,180 funds tracked by Wall St. Rank hold NVS as of Q1 2023.
- Westwood Holdings Group reported no remaining Novartis position as of Q1 2023 after selling out during the quarter.
- Westwood Holdings Group sold 12,712 Novartis shares in Q1 2023, an estimated $1.15M.
- Westwood Holdings Group first reported a position in Novartis in Q2 2013 and held it in 36 quarters.
- Westwood Holdings Group's Novartis position peaked at $141M in Q4 2013.
- 1,180 funds tracked by Wall St. Rank held Novartis as of Q1 2023.
Based on Westwood Holdings Group's 13F filing for Q1 2023, filed 12 May 2023.